Cardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
August 4, 2016 8:14 AM EDTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from $23.00), following the company's 4Q earnings report. Revenue was $48.5M vs. consensus of $46.0M and GAAP EPS was ($0.15) vs. consensus of ($0.20).
Analyst Mike Matson... More
BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to Neutral
August 4, 2016 6:51 AM EDTBofA/Merrill Lynch upgraded Cardiovascular Systems (NASDAQ: CSII) from Underperform to Neutral.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $19.74 yesterday.
... More